Taejeon-si, South Korea

Jeong Hyung Lee


Average Co-Inventor Count = 9.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jeong Hyung Lee in Metabolic Disorder Treatment

Introduction

Jeong Hyung Lee is a prominent inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the treatment of metabolic disorders. With a total of 2 patents, his work focuses on innovative methods to combat diseases such as obesity and diabetes.

Latest Patents

One of his latest patents is a method for the treatment of metabolic disorders containing benzazole derivatives as an active ingredient. This composition is designed for the prevention and treatment of metabolic diseases, utilizing a benzazole derivative that exhibits inhibitory activity against DGAT (diacylglycerol acyltransferase). This enzyme is known to contribute to metabolic diseases during lipid metabolism. The composition effectively controls lipid and energy metabolism, making it a valuable tool in addressing conditions like obesity and diabetes.

Another notable patent involves indole derivatives, which also serve as an active ingredient in a composition aimed at preventing and treating metabolic disorders. Similar to the benzazole derivatives, these indole derivatives inhibit DGAT activity, thereby aiding in the management of metabolic diseases. The ability to regulate lipid and energy metabolism positions this composition as a promising solution for combating obesity and diabetes.

Career Highlights

Jeong Hyung Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on groundbreaking research that addresses critical health issues related to metabolic disorders.

Collaborations

He has collaborated with notable colleagues, including Kyeong Seok Lee and Hyun Sun Lee, to further advance research in this vital area of health.

Conclusion

Jeong Hyung Lee's innovative contributions to the treatment of metabolic disorders highlight the importance of research in biotechnology. His patents reflect a commitment to developing effective solutions for obesity and diabetes, showcasing the potential of scientific advancements in improving public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…